Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (51-60 of 746) with videos related to

Pageof 75
Sort By:
Proceedings (Baylor University. Medical Center)|April 2, 2016
Arm pain and erythemaBrandon M Barth, Andrew L Juergens
Current Oncology (Toronto, Ont.)|December 13, 2021
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung CancerCourtney H Coschi, Rosalyn A Juergens
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Adjuvant treatment in non-small cell lung cancer: Where are we now?Rosalyn A Juergens, Julie R Brahmer
Molecular and Cellular Biochemistry|January 12, 1996
Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxiaT M Juergens, C D Hardin
Internal Medicine Journal|October 3, 2007
Non-STEMI or no NSTEMI?J Gohil, C Juergens, J French
Deutsche Medizinische Wochenschrift (1946)|July 2, 2008
[Methods to improve patient's adherence: is there hope?]A Gillissen, U Juergens, K Büsch
Deutsche Medizinische Wochenschrift (1946)|June 2, 2007
[Adherence to therapy in bronchial asthma]A Gillissen, K Büsch, U Juergens
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic targetRosalyn A Juergens, Charles M Rudin
The Medical Clinics of North America|July 1, 1974
Thrombophlebitis and pulmonary embolism as complications of pregnancyL A Aaro, J L Juergens
Current Oncology (Toronto, Ont.)|January 26, 2024
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune ResponseCourtney H Coschi, Rosalyn A Juergens
Pageof 75

Showing results (51-60 of 746) with videos related to

Sort By:
Pageof 75
Proceedings (Baylor University. Medical Center)|April 2, 2016
Arm pain and erythemaBrandon M Barth, Andrew L Juergens
Current Oncology (Toronto, Ont.)|December 13, 2021
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung CancerCourtney H Coschi, Rosalyn A Juergens
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
Adjuvant treatment in non-small cell lung cancer: Where are we now?Rosalyn A Juergens, Julie R Brahmer
Molecular and Cellular Biochemistry|January 12, 1996
Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxiaT M Juergens, C D Hardin
Internal Medicine Journal|October 3, 2007
Non-STEMI or no NSTEMI?J Gohil, C Juergens, J French
Deutsche Medizinische Wochenschrift (1946)|July 2, 2008
[Methods to improve patient's adherence: is there hope?]A Gillissen, U Juergens, K Büsch
Deutsche Medizinische Wochenschrift (1946)|June 2, 2007
[Adherence to therapy in bronchial asthma]A Gillissen, K Büsch, U Juergens
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic targetRosalyn A Juergens, Charles M Rudin
The Medical Clinics of North America|July 1, 1974
Thrombophlebitis and pulmonary embolism as complications of pregnancyL A Aaro, J L Juergens
Current Oncology (Toronto, Ont.)|January 26, 2024
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune ResponseCourtney H Coschi, Rosalyn A Juergens
Pageof 75